pharma news

News

Graphic of pile of gold coins and green shoots on blue background

Syneron raises $150m for macrocyclics, and other financings

Our round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder.

News

Activist investor renews its criticism of Novavax

Shah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a "destruction in shareholder value."

News

Jeito's founder and president, Dr Rafaèle Tordjman

Jeito closes 'record' $1.2bn Europe-focused biopharma fund

Jeito Capital has closed its second fund, raking in €1bn, which it claims is the largest ever raise for an independent European biopharma fund.

News

EU invests €30m to fight antimicrobial resistance

The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

News

US judge blocks bid to curb abortion pill access

A bid to limit access to the abortion pill mifepristone in the US, while the FDA carries out a review of the drug, has been blocked in the courts.

News

Gilead strikes again, penning $5bn deal to buy Tubulis

Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.

Syneron raises $150m for macrocyclics, and other financings

Activist investor renews its criticism of Novavax

Jeito closes 'record' $1.2bn Europe-focused biopharma fund

EU invests €30m to fight antimicrobial resistance

US judge blocks bid to curb abortion pill access

Gilead strikes again, penning $5bn deal to buy Tubulis

Australia starts probe into AI infiltration of Medicare

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks